Canada Life’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-30,446
Closed -$2.68M 2617
2017
Q3
$2.68M Sell
30,446
-497
-2% -$43.6K 0.01% 966
2017
Q2
$2.69M Buy
30,943
+992
+3% +$74K 0.01% 944
2017
Q1
$1.89M Sell
29,951
-482
-2% -$31.9K 0.01% 1177
2016
Q4
$2M Sell
30,433
-622
-2% -$39K 0.01% 1090
2016
Q3
$2.15M Hold
31,055
0.01% 1010
2016
Q2
$1.95M Buy
31,055
+25,429
+452% +$1.57M 0.01% 1033
2016
Q1
$352K Hold
5,626
﹤0.01% 1027
2015
Q4
$383K Hold
5,626
﹤0.01% 991
2015
Q3
$349K Buy
5,626
+1,282
+30% +$86.2K ﹤0.01% 982
2015
Q2
$279K Hold
4,344
﹤0.01% 1198
2015
Q1
$299K Hold
4,344
﹤0.01% 1139
2014
Q4
$241K Hold
4,344
﹤0.01% 1215
2014
Q3
$275K Hold
4,344
﹤0.01% 1087
2014
Q2
$229K Buy
4,344
+1,616
+59% +$81K ﹤0.01% 1074
2014
Q1
$147K Hold
2,728
﹤0.01% 1245
2013
Q4
$124K Buy
+2,728
New +$125K ﹤0.01% 1322

Other funds holding PRXL

Canada Life's PRXL Position: Q4 2017 in Review

Canada Life sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 30,446 shares — an estimated $2.68M sold.

Canada Life first reported a position in PRXL in Q4 2013 and held it in 16 quarters. The position peaked at $2.69M in Q2 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.

  • Canada Life reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
  • Canada Life sold 30,446 Parexel International Corp shares in Q4 2017, an estimated $2.68M.
  • Canada Life first reported a position in Parexel International Corp in Q4 2013 and held it in 16 quarters.
  • Canada Life's Parexel International Corp position peaked at $2.69M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.

Based on Canada Life's 13F filing for Q4 2017, filed 9 Feb 2018.